Posts

The Long-COVID Crisis: No Cure, Little Attention

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded. Medscape News Europe source https://www.medscape.com/viewarticle/long-covid-crisis-no-cure-little-attention-2026a1000cmk?src=rss

Longer ED Stay Linked to Early Clinical Deterioration

A longer stay in the emergency department is associated with an increased risk for early clinical deterioration among patients, a study finds. Medscape Medical News source https://www.medscape.com/viewarticle/longer-ed-stay-linked-early-clinical-deterioration-2026a1000cdt?src=rss

PT Beats CBT for First-Line Low Back Pain Treatment

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy. Medscape Medical News source https://www.medscape.com/viewarticle/pt-safe-and-effective-first-line-treatment-chronic-low-back-2026a1000cez?src=rss

Discoid Lupus: Hydroxychloroquine Linked to Lower CV Risk

Early use of hydroxychloroquine in adults with isolated discoid lupus is linked to lower 5-year rates of hyperlipidemia, coronary artery disease, and stroke, a study shows. Medscape Medical News source https://www.medscape.com/viewarticle/discoid-lupus-hydroxychloroquine-linked-lower-cardiovascular-2026a1000ces?src=rss

Extreme Heat May Increase ED Visits in Some Older Adults

Extreme heat is linked to increased ED visits in older adults treated at hospitals serving low-income, minoritized populations but not in those treated at hospitals serving higher-income populations. Medscape Medical News source https://www.medscape.com/viewarticle/extreme-heat-may-increase-ed-visits-older-adults-low-income-2026a1000c96?src=rss

Immunotherapy Combo Shows Promise for Hodgkin Lymphoma

A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma. Medscape Medical News source https://www.medscape.com/viewarticle/immunotherapy-combo-shows-promise-hodgkin-lymphoma-2026a1000c8x?src=rss